CVC Capital Partners leads consortium in €3.03bn acquisition of Recordati
In a landmark deal valued at approximately €3.03 billion, a consortium led by CVC Capital Partners through its CVC Fund VII has acquired a 51.8% stake in the Italian pharmaceutical company, Recordati. The consortium also includes notable investors such as Canada’s Public Sector Pension Investment Board (PSP Investments) and US-based StepStone. Strategic Implications of the […]